Events

View All

    AACR 2023: In vivo Efficacy Evaluation of Anti-Human VEGFR2 Antibodies in Humanized B-hVEGFR2 Mice

    April 18, 2023
    Share on:
    Conclusions

    mRNA expression analysis:

    Murine Vegfr2 mRNA was detected in embryonic tissue isolated from wild-type mice, while human VEGFR2 mRNA was detected in B-hVEGFR2 mice. Protein expression analysis:

    Murine VEGFR2 protein was detected in wild-type mice, while human VEGFR2 protein was detected in B-hVEGFR2 mice. In vivo efficacy:

    Anti-human VEGFR2 antibody was effective in controlling MC38 tumor growth in B-hVEGFR2 mice and inhibits vascular endothelial cell proliferation.